2-(N,N-diethylamino)-3-nitro-6-(1-piperazinyl)pyridine | 125173-54-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: 2-(N,N-diethylamino)-3-nitro-6-(1-piperazinyl)pyridine
• 英文别名: N,N-diethyl-3-nitro-6-piperazin-1-ylpyridin-2-amine
• CAS: 125173-54-8
• 化学式: C₁₃H₂₁N₅O₂
• 分子量: 279.342
• InChiKey: OBKVGKNMUFIGCA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  20
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.62
• 拓扑面积：
  77.2
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  2-(N,N-diethylamino)-3-nitro-6-(1-piperazinyl)pyridine 在 palladium on activated charcoal 盐酸 、 氢气 、 sodium cyanoborohydride 、 三乙胺 作用下， 以 乙醇 、 二氯甲烷 、 乙酸乙酯 、 乙腈 为溶剂， 25.0 ℃ 、317.16 kPa 条件下， 反应 96.0h， 生成 2,3-bis(N,N-diethylamino)-6-(1-piperazinyl)pyridine
  参考文献：
  名称：

  Novel 21-aminosteroids that inhibit iron-dependent lipid peroxidation and protect against central nervous system trauma

  摘要：

  A novel class of 21-aminosteroids has been developed. Compounds within this series are potent inhibitors of iron-dependent lipid peroxidation in rat brain homogenates with IC50's as low as 3 microM. Furthermore, selected members enhance early neurological recovery and survival in a mouse head injury model. Significant improvement in the 1 h post-head-injury neurological status (grip test score) by as much as 168.6% of the control has been observed. The most efficacious compound in this assay (30) showed an increase in the 1-week survival of 78.6% as compared to 27.3% for the vehicle-treated mice in the head-injury model. Based on its biological profile, 21-[4-(2,6-di-1-pyrrolidinyl-4-pyrimidinyl)-1-piperazinyl]-16 alpha- methylpregna-1,4,9(11)-triene-3,20-dione monomethanesulfonate (30) was selected for further evaluation and is currently entering phase I clinical trials for the treatment of head and spinal trauma.

  DOI：

  10.1021/jm00166a010
• 作为产物：
  描述：

  2,6-二氯-3-硝基吡啶 在 potassium carbonate 作用下， 以 乙腈 为溶剂， 反应 3.67h， 生成 2-(N,N-diethylamino)-3-nitro-6-(1-piperazinyl)pyridine
  参考文献：
  名称：

  Novel 21-aminosteroids that inhibit iron-dependent lipid peroxidation and protect against central nervous system trauma

  摘要：

  A novel class of 21-aminosteroids has been developed. Compounds within this series are potent inhibitors of iron-dependent lipid peroxidation in rat brain homogenates with IC50's as low as 3 microM. Furthermore, selected members enhance early neurological recovery and survival in a mouse head injury model. Significant improvement in the 1 h post-head-injury neurological status (grip test score) by as much as 168.6% of the control has been observed. The most efficacious compound in this assay (30) showed an increase in the 1-week survival of 78.6% as compared to 27.3% for the vehicle-treated mice in the head-injury model. Based on its biological profile, 21-[4-(2,6-di-1-pyrrolidinyl-4-pyrimidinyl)-1-piperazinyl]-16 alpha- methylpregna-1,4,9(11)-triene-3,20-dione monomethanesulfonate (30) was selected for further evaluation and is currently entering phase I clinical trials for the treatment of head and spinal trauma.

  DOI：

  10.1021/jm00166a010

文献信息

• Amines useful in producing pharmaceutically active CNS compounds
  申请人：Upjohn Company

  公开号：US05099019A1

  公开（公告）日：1992-03-24

  Disclosed are .DELTA..sup.9(11) -steroids (VI) and amino substituted steroids (XI) which contain an amino group attached to the terminal carbon atom of the C.sub.17 -side chain, more particularly amino steroids (Ia and Ib), aromatic steroids (II), .DELTA..sup.16 -steroids (IIIa and IIIb), reduced A-ring steroids (IV), .DELTA..sup.17(20) -steroids (Va and Vb) and .DELTA..sup.9(11) -steroids (VI) which are useful as pharmaceutical agents for treating a number of conditions.

  披露了包含连接到C.sub.17-侧链的末端碳原子的氨基类固醇（VI）和氨基取代类固醇（XI），更具体地是氨基类固醇（Ia和Ib），芳香类固醇（II），Δ9(11)-类固醇（IIIa和IIIb），还原A环类固醇（IV），Δ17(20)-类固醇（Va和Vb）和Δ9(11)-类固醇（VI），这些类固醇可用作治疗多种疾病的药物。
• Pharmaceutically active amines
  申请人：Upjohn

  公开号：US05120843A1

  公开（公告）日：1992-06-09

  The aromatic amines (I), alkyl amines (II), bicyclic amines (III). ##STR1## cycloalkyl amines (IV), aromatic bicyclic amines (V), hydroquinone amines (VI), quinone amines (VII), amino-ethers (VIII) and bicyclic amino ethers (IX) are useful as pharmaceutical agents for treating a number of conditions including spinal trauma, mild and/or moderate to severe head injury, etc. Also disclosed is a method of treatment using the 3,4-dihydrobenzopyrans (XI).

  芳香胺（I），烷基胺（II），双环胺（III），环烷基胺（IV），芳香双环胺（V），氢醌胺（VI），醌胺（VII），氨基醚（VIII）和双环氨基醚（IX）可用作治疗多种疾病的药物，包括脊椎创伤、轻微和/或中度至严重头部损伤等。还公开了一种使用3,4-二氢苯并吡喯（XI）的治疗方法。
• US35053
  申请人：——

  公开号：——

  公开（公告）日：——
• C20 Through C26 amino steroids
  申请人：THE UPJOHN COMPANY

  公开号：EP0263213B1

  公开（公告）日：1995-09-06
• JACOBSEN, E. JON;MCCALL, JOHN M.;AYER, DONALD E.;VAN, DOORNIK FRED J.;PAL+, J. MED. CHEM., 33,(1990) N, C. 1145-1151
  作者：JACOBSEN, E. JON、MCCALL, JOHN M.、AYER, DONALD E.、VAN, DOORNIK FRED J.、PAL+

  DOI：——

  日期：——